Genentech
Genentech reports positive Phase II data of Port Delivery System
Roche subsidiary Genentech has reported positive, top-line data from a Phase II clinical trial (LADDER) conducted to assess its Port…
Roche subsidiary Genentech has reported positive, top-line data from a Phase II clinical trial (LADDER) conducted to assess its Port…